Cargando…

Real-world challenge for clinicians treating advanced gastroesophageal adenocarcinoma (Review)

Gastroesophageal adenocarcinoma (GOA) is a disease of older people. Incidence is rising in the developed world and the majority of patients present with advanced disease. Based on clinical trial data, systemic chemotherapy in the advanced setting is associated with improvements in quality of life an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baxter, Mark A., Petty, Russell D., Swinson, Daniel, Hall, Peter S., O'Hanlon, Shane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979263/ https://www.ncbi.nlm.nih.gov/pubmed/33760115 http://dx.doi.org/10.3892/ijo.2021.5202

Ejemplares similares

Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial
por: Baxter, Mark A., et al.
Publicado: (2023)

Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial
por: Pearce, Jessica, et al.
Publicado: (2022)

Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress
por: Gambardella, Valentina, et al.
Publicado: (2020)

Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
por: Zhao, Dan, et al.
Publicado: (2019)

Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
por: Barzi, Afsaneh, et al.
Publicado: (2019)

Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States
por: Mehta, Rutika, et al.
Publicado: (2023)

ASO Author Reflections: Challenges in the Management of Gastroesophageal Junctional Adenocarcinoma
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma
por: Wang, Xin, et al.
Publicado: (2022)

Breast clinicians: their contribution to the breast screening programme in England and implications of the current age structure
por: Swinson, C
Publicado: (2012)

ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti–Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma
por: Zhang, Liangliang, et al.
Publicado: (2022)

Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis
por: Walden, Daniel, et al.
Publicado: (2021)

Positioning of second‐line treatment for advanced gastric and gastroesophageal junction adenocarcinoma
por: Pericay, Carles, et al.
Publicado: (2016)

A Comparison of Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving First-Line Therapy for Unresectable Advanced Gastric or Gastroesophageal Junction Cancer Versus Esophageal Adenocarcinomas
por: Shankaran, Veena, et al.
Publicado: (2020)

Real-world Validation of TMB and Microsatellite Instability as Predictive Biomarkers of Immune Checkpoint Inhibitor Effectiveness in Advanced Gastroesophageal Cancer
por: Graf, Ryon P., et al.
Publicado: (2022)

Role of Immunotherapy in Gastroesophageal Cancers—Advances, Challenges and Future Strategies
por: Lynch, Emer, et al.
Publicado: (2023)

Combination of apatinib mesylate and second-line chemotherapy for treating gastroesophageal junction adenocarcinoma
por: Lu, Bin, et al.
Publicado: (2019)

Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative Chemotherapy
por: Ballhausen, Alexej, et al.
Publicado: (2022)

Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management?
por: Cagney, Hannah P., et al.
Publicado: (2023)

Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
por: Blonde, Lawrence, et al.
Publicado: (2018)

Real World Evidence — Need for Physician-Scientist/Clinician-Researcher
por: Meeta, Meeta, et al.
Publicado: (2021)

Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
por: Vázquez-López, Rosalino, et al.
Publicado: (2020)

Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)
por: Han, Hye Sook, et al.
Publicado: (2021)

Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma
por: Koch, Christine, et al.
Publicado: (2019)

Gastroesophageal junction adenocarcinoma metastasizing to gingiva
por: Masamatti, Smita S, et al.
Publicado: (2013)

Customization of therapy for gastroesophageal adenocarcinoma patients
por: Mizrak Kaya, Dilsa, et al.
Publicado: (2018)

Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
por: Kim, Jin-Jo
Publicado: (2018)

Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers
por: Baxter, Mark A., et al.
Publicado: (2021)

A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO)
por: Hall, P S, et al.
Publicado: (2017)

Higher Dementia Risk in People With Gastroesophageal Reflux Disease: A Real-World Evidence
por: Gau, Shuo-Yan, et al.
Publicado: (2022)

Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada
por: Ding, Philip Q., et al.
Publicado: (2022)

Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers
por: Chuang, Jeremy, et al.
Publicado: (2022)

Pragmatic AI-augmentation in mental healthcare: Key technologies, potential benefits, and real-world challenges and solutions for frontline clinicians
por: Kellogg, Katherine C., et al.
Publicado: (2022)

Challenges for clinicians treating autoimmune pancreatitis: Current perspectives
por: Kim, Seong-Hun, et al.
Publicado: (2023)

Independent Stage Classification for Gastroesophageal Junction Adenocarcinoma
por: Hirata, Yuki, et al.
Publicado: (2023)

Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
por: Kesavadev, Jothydev, et al.
Publicado: (2023)

Elective advice
por: O’Hanlon, Shane
Publicado: (2007)

The Comfort of Poetry in a Pandemic
por: O’Hanlon, Shane
Publicado: (2022)

A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma
por: Burge, M E, et al.
Publicado: (2006)

(Neo)Adjuvant Treatment of Locally Advanced Esophageal and Gastroesophageal Adenocarcinoma: Special Focus on Sex Differences
por: Zander, Thomas, et al.
Publicado: (2022)

Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
por: Plazas, J. Gallego, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6imodop0nji0tn7agsgloefs6f